ArticleJournal of surgical case reports2026
Report on a case of giant retroperitoneal perirenal liposarcoma with kidney preservation.
Article in Journal of surgical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Retroperitoneal liposarcoma is an uncommon malignant tumor and a subtype of soft tissue sarcoma. Early diagnosis is particularly challenging due to the tumour's location in the retroperitoneal space, which provides ample room for expansion. Symptoms typically manifest only when the tumor reaches a substantial size or invades adjacent organs. We report a case of a 61-year-old woman who underwent surgical resection for a well-differentiated liposarcoma. Computed tomography scan revealed that the mass invaded the left perirenal fascia and displaced the descending colon, pancreas, and duodenum. Complete resection of tumour masses was performed, and we opted to preserve the kidney due to no visible renal parenchymal tumour invasion. The management of retroperitoneal perirenal liposarcoma typically entails the implementation of an R0 resection. If a tumor extends into an adjacent tissue, one must consider the benefits of achieving clear surgical margins versus the risks of medical issues and reduced quality of life.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.